Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2025-10-01 Regulatory Filings
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2025-10-01 Korean
[기재정정]주요사항보고서(회사합병결정)
Regulatory Filings
2025-09-29 Korean
[기재정정]증권신고서(합병)
Regulatory Filings
2025-09-29 Korean
주요사항보고서(전환사채권발행결정)
Regulatory Filings
2025-09-24 Korean
주주명부폐쇄기간또는기준일설정
M&A Activity Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for shareholder list closure due to a small-scale merger. It is not a full report, but rather a specific regulatory disclosure required by the exchange. Since it does not fit into specific categories like M&A (which is the 'related' disclosure) or dividend announcements, it falls under the general regulatory filing category.
2025-09-18 Korean
증권신고서(합병)
M&A Activity Classification · 1% confidence The document is a '증권신고서(합병)' (Securities Registration Statement for Merger) filed by HLB Co., Ltd. with the Financial Services Commission of South Korea. It contains detailed information regarding the merger, business risks, financial status, and investment risks associated with the transaction. This type of regulatory filing for a merger is classified under the 'Regulatory Filings' category as it is a formal legal document required by the regulator for corporate actions that do not fit into the other specific categories like 10-K or Earnings Release.
2025-09-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.